SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Vitali C, Palombi G, Baldini C, Benucci M, Bombardieri S, Covelli M, et al. Sjögren's Syndrome Disease Damage Index and Disease Activity Index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum 2007; 56: 222331.
  • 2
    Bowman SJ, Sutcliffe N, Isenberg DA, Goldblatt F, Adler M, Price E, et al. Sjögren's Systemic Clinical Activity Index (SCAI): a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome. Rheumatology (Oxford) 2007; 46: 184551.
  • 3
    Seror R, Ravaud P, Bowman S, Baron G, Tzioufas A, Theander E, et al. EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI): development of a consensus systemic disease activity index in primary Sjögren's syndrome. Ann Rheum Dis 2009. E-pub ahead of print.
  • 4
    Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis 1987; 40: 1718.
  • 5
    Guyatt GH, Kirshner B, Jaeschke R. Measuring health status: what are the necessary measurement properties? J Clin Epidemiol 1992; 45: 13415.
  • 6
    Norman GR. Issues in the use of change scores in randomized trials. J Clin Epidemiol 1989; 42: 1097105.
  • 7
    Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 5548.
  • 8
    Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993; 86: 44758.
  • 9
    Barry RJ, Sutcliffe N, Isenberg DA, Price E, Goldblatt F, Adler M, et al. The Sjögren's Syndrome Damage Index: a damage index for use in clinical trials and observational studies in primary Sjögren's syndrome. Rheumatology (Oxford) 2008; 47: 11938.
  • 10
    Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999; 8: 13560.
  • 11
    Marx RG, Menezes A, Horovitz L, Jones EC, Warren RF. A comparison of two time intervals for test–retest reliability of health status instruments. J Clin Epidemiol 2003; 56: 7305.
  • 12
    Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman and Hall; 1993.
  • 13
    Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960; 20: 3746.
  • 14
    Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 1968; 70: 21320.
  • 15
    Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopedic evaluation. Med Care 1990; 28: 63242.
  • 16
    Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Erlbaum Associates; 1988.
  • 17
    Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989; 27: S17889.
  • 18
    Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. 4th ed. New York: Oxford University Press; 2008.
  • 19
    Husted JA, Cook RJ, Farewell VT, Gladman DD. Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol 2000; 53: 45968.
  • 20
    Agresti A. Categorical data analysis. 2nd ed. New York: John Wiley & Sons; 2002.
  • 21
    Fortin PR, Abrahamowicz M, Clarke AE, Neville C, Du Berger R, Fraenkel L, et al. Do lupus disease activity measures detect clinically important change? J Rheumatol 2000; 27: 14218.
  • 22
    American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity. Arthritis Rheum 2004; 50: 341826.
  • 23
    Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. 2nd ed. New York: Oxford University Press; 1996.
  • 24
    Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 63040.
  • 25
    Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29: 28891.